Schedule 13D ownership disclosure

Regencell Bioscience Holdings Ltd.

Security class unavailable · CUSIP: G7487R100

Event date: 2021-11-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,342,105
Percent of class
79.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-061019
Form type
SC 13D/A
Filer
Regencell (BVI) Ltd
CIK
CIK 1874958
Filed
Nov 22, 2021
Reporting period
Nov 19, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub